Sarcoidosis 1

Common Name(s)

Sarcoidosis 1

Idiopathic scoliosis is a structurally fixed lateral curvature of the spine with a rotatory component. There is at least a 10 degree curvature as demonstrated by upright spine roentgenograms by the Cobb method ({16:Weinstein, 1994}).
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Sarcoidosis 1" for support, advocacy or research.

Logo
Foundation for Sarcoidosis Research

The Foundation for Sarcoidosis Research is the nation's leading nonprofit organization dedicated to finding a cure for this disease and to improving care for sarcoidosis patients. Since its establishment in 2000, FSR has funded numerous domestic and international research efforts and worked diligently to provide resources to thousands.

Last Updated: 19 Feb 2013

View Details
Logo
Sarcoidosis Australia

Bring fellow sufferers together to support each other and their families Provide and share information and experiences, acting as a forum to help those affected to understand the condition Support the medical profession in the early diagnosis and treatment of those with these diseases Support the medical profession in research into the disease Heighten awareness of the disease in Australia

Last Updated: 2 Mar 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Sarcoidosis 1" for support, advocacy or research.

Logo
Foundation for Sarcoidosis Research

The Foundation for Sarcoidosis Research is the nation's leading nonprofit organization dedicated to finding a cure for this disease and to improving care for sarcoidosis patients. Since its establishment in 2000, FSR has funded numerous domestic and international research efforts and worked diligently to provide resources to thousands.

http://www.stopsarcoidosis.org

Last Updated: 19 Feb 2013

View Details
Logo
Sarcoidosis Australia

Bring fellow sufferers together to support each other and their families Provide and share information and experiences, acting as a forum to help those affected to understand the condition Support the medical profession in the early diagnosis and treatment of those with these diseases Support the medical profession in research into the disease Heighten awareness of the disease in Australia

http://www.sarcoidosisaustralia.com

Last Updated: 2 Mar 2013

View Details

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Sarcoidosis 1" returned 41 free, full-text research articles on human participants. First 3 results:

IFN-γ-Producing T-Helper 17.1 Cells Are Increased in Sarcoidosis and Are More Prevalent than T-Helper Type 1 Cells.
 

Author(s): Joris Ramstein, Caroline E Broos, Laura J Simpson, K Mark Ansel, Sara A Sun, Melissa E Ho, Prescott G Woodruff, Nirav R Bhakta, Laura Christian, Christine P Nguyen, Bobby J Antalek, Bryan S Benn, Rudi W Hendriks, Bernt van den Blink, Mirjam Kool, Laura L Koth

Journal: Am. J. Respir. Crit. Care Med.. 2016 Jun;193(11):1281-91.

 

Pulmonary sarcoidosis is classically defined by T-helper (Th) cell type 1 inflammation (e.g., IFN-γ production by CD4(+) effector T cells). Recently, IL-17A-secreting cells have been found in lung lavage, invoking Th17 immunity in sarcoidosis. Studies also identified IL-17A-secreting ...

Last Updated: 2 Jun 2016

Go To URL
Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) Study. Sarcoidosis Protocol.
 

Author(s): David R Moller, Laura L Koth, Lisa A Maier, Alison Morris, Wonder Drake, Milton Rossman, Joseph K Leader, Ronald G Collman, Nabeel Hamzeh, Nadera J Sweiss, Yingze Zhang, Scott O'Neal, Robert M Senior, Michael Becich, Harry S Hochheiser, Naftali Kaminski, Stephen R Wisniewski, Kevin F Gibson,

Journal: Ann Am Thorac Soc. 2015 Oct;12(10):1561-71.

 

Sarcoidosis is a systemic disease characterized by noncaseating granulomatous inflammation with tremendous clinical heterogeneity and uncertain pathobiology and lacking in clinically useful biomarkers. The Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis (GRADS) ...

Last Updated: 9 Oct 2015

Go To URL
Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
 

Author(s): Charlie Strange, Robert M Senior, Frank Sciurba, Scott O'Neal, Alison Morris, Stephen R Wisniewski, Russell Bowler, Harry S Hochheiser, Michael J Becich, Yingze Zhang, Joseph K Leader, Barbara A Methé, Naftali Kaminski, Robert A Sandhaus,

Journal: Ann Am Thorac Soc. 2015 Oct;12(10):1551-60.

 

Severe deficiency of alpha-1 antitrypsin has a highly variable clinical presentation. The Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis α1 Study is a prospective, multicenter, cross-sectional study of adults older than age 35 years with PiZZ or PiMZ alpha-1 antitrypsin ...

Last Updated: 9 Oct 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Sarcoidosis 1" returned 3 free, full-text review articles on human participants. First 3 results:

The Roles of T Helper 1, T Helper 17 and Regulatory T Cells in the Pathogenesis of Sarcoidosis.
 

Author(s): Esmaeil Mortaz, Fatemeh Rezayat, Davar Amani, Arda Kiani, Johan Garssen, Ian M Adcock, Aliakbar Velayati

Journal: Iran J Allergy Asthma Immunol. 2016 Aug;15(4):334-339.

 

Sarcoidosis is a systemic granulomatous disorder of unidentified etiology, with a heterogeneous clinical presentation. It is characterized by a reduced delayed-type hypersensitivity to tuberculin and common antigens. The balance between Th1, Th17 and Regulatory T(Treg) cells controls ...

Last Updated: 6 Dec 2016

Go To URL
Atypical Presentation of Sarcoidosis on ¹⁸F-FDG PET/CT.
 

Author(s): Prashant Jolepalem, Katie Zanyk McLean, Ching-Yee Oliver Wong

Journal: J Nucl Med Technol. 2014 Jun;42(2):114-5.

 

On (18)F-FDG PET, inflammatory processes can be one of the most confounding factors for interpretation, particularly when the presentation of the process is atypical, as it was in the case of sarcoidosis reported here. Clinicians should be aware that sarcoidosis may mimic lung malignancies ...

Last Updated: 2 May 2015

Go To URL
Primary care paradigm for management of sarcoidosis, Part 1.
 

Author(s): R C Young, R E Rachal, B Nelson-Knuckles, C N Arthur, H V Nevels

Journal: J Natl Med Assoc. 1997 Mar;89(3):181-90.

 

Sarcoidosis is a systemic granulomatous disease of undetermined etiology in which the immune system is overstimulated. Management of the patient with sarcoidosis entails continuity of patient care far beyond disease, even into remission. Care is comprehensive, including all involved ...

Last Updated: 7 May 1997

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome
 

Status: Recruiting

Condition Summary: Sjögren's Syndrome

 

Last Updated: 31 Jan 2016

Go to URL

Last Updated: 1 Aug 2016

Go to URL
Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome
 

Status: Recruiting

Condition Summary: Myelodysplastic Syndromes

 

Last Updated: 5 Feb 2017

Go to URL